Big4Bio:Philly

@Big4BioPhilly

Part of the life science hub coverage network. Subscribe to the Big4Bio:Philly daily newsletter for FREE:

Philadelphia, PA
Vrijeme pridruživanja: svibanj 2019.

Tweetovi

Blokirali ste korisnika/cu @Big4BioPhilly

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Big4BioPhilly

  1. 31. sij

    "What we are hypothesizing here is that there can be a third mechanism…that even in the presence of CD19 those leukemic cells are unable to die when they are triggered by CAR-T."

    Poništi
  2. proslijedio/la je Tweet
    31. sij

    We're seeking disruptive solutions to threats and together with offering the right support at the right time to and protect Americans from health security threats.

    Poništi
  3. 31. sij

    2019 has been a brilliant year for the Greater Philadelphia region! Learn why inside Big4Bio's Year-in-Review report for Philadelphia:

    Poništi
  4. proslijedio/la je Tweet

    Proteins, fats, carbohydrates and the very building blocks of all living things – DNA – are all organic molecules. Check out how assistant professor John Milligan is using blue light to develop these molecules.  

    Poništi
  5. 30. sij
    Poništi
  6. 30. sij

    Review the year that's been—grab a copy of the 2019 Year-in-Review report for the Greater Philadelphia region!

    Poništi
  7. 30. sij

    . researchers found that an existing anticancer drug called SAHA helped animals with a condition known as heart failure with preserved ejection fraction.

    Poništi
  8. 30. sij

    The Greater Philadelphia community almost tripled its venture funding in 2019. Look through the just-released Year-in-Review for Greater Philadelphia for key information on the news stories and deals from 2019!

    Poništi
  9. proslijedio/la je Tweet
    30. sij

    "Next week, we will be meeting with some of our SPEARHEAD-1 investigators, as well as patient groups and other partners, during the & GIST symposium. Let us know if you would want to meet. "

    Poništi
  10. 29. sij

    "This could allow clinicians to administer CAR T cell therapies in doses to target cancer cells without damaging as many healthy cells in the process, thus mitigating the side effects."

    Poništi
  11. proslijedio/la je Tweet
    29. sij

    Cell And Gene Therapy Foresight In 2020: 7 Trends To Watch by Bruce Levine , PhD in "Cell & Gene"

    Poništi
  12. 29. sij

    Attend the 14th Annual Hub and SPP Model Optimization event, which will feature manufacturers, pharmacies, PBMs and more, on February 24-26, 2020, at the Loews Philadelphia Hotel. Register today!

    Poništi
  13. proslijedio/la je Tweet
    29. sij

    Start the year off right by registering for a table at the Life Sciences Pennsylvania 2020 Annual Dinner! Click and register today!

    Poništi
  14. 28. sij

    Harmony will help commercialize its first drug WAKIX® (pitolisant) tablets, which was approved in August 2019, with the debt facility from OrbiMed.

    Poništi
  15. proslijedio/la je Tweet
    28. sij

    Our second Speaker Series event is this Thursday - January 30th! Featuring both Shahram Hejazi PhD, and Rick Jones MD, MBA as our speakers! Sign up here! ⬇️ Cant be there in person? Tune in to our live-stream! 🌐📺

    Poništi
  16. proslijedio/la je Tweet
    28. sij

    Register by today to secure reduced rates on housing for the CEO & Investor Conference on 2/10-2/11 in New York, NY! register with code BIOCEO1 and save up to $200! LEARN MORE:

    Poništi
  17. 28. sij

    "Bruce is ideally suited to lead Passage Bio as chief executive officer given his strong neuroscience background coupled with his robust healthcare and biotechnology industry experience."

    Poništi
  18. proslijedio/la je Tweet
    28. sij
    Poništi
  19. 27. sij

    Since news of Inovio's new source of funding for its development of a vaccine against the coronavirus from China, its shares have risen 26%.

    Poništi
  20. proslijedio/la je Tweet
    27. sij

    "Today's announcement should further increase investors' confidence that Skyrizi will not be part of the divestiture plan in the US."

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·